GSK (GSK) plc announced that it has completed the acquisition of IDRx, Inc., a Boston-based, clinical-stage biopharmaceutical company dedicated ...

GSK completes acquisition of Boston-based, clinical-stage biopharma company, IDRx, Inc.

Profiling cells from ovarian endometriosis revealed signaling interactions that may sustain lesion growth, highlighting ...

Graft-versus-host disease (GVHD) is a common and severe complication that occurs after stem cell transplantation, where the donor's immune cells attack the recipient's tissues. Ocular manifestation of ...

GSK plc has completed its previously announced acquisition of IDRx Inc., a Boston-based, clinical-stage biopharmaceutical ...

Learn about Pseudoangiomatous Stromal Hyperplasia (PASH) of the breast, its diagnosis, hormonal influences, and holistic ...

The prognosis of patients with gastrointestinal stromal tumors is significantly impacted by gastrointestinal bleeding.

A study found that injecting mesenchymal stem cells into periocular tissue effectively reduces eye inflammation without ...

GSK plc (LSE/NYSE: GSK) today announced that it has completed the acquisition of IDRx, Inc. (IDRx), a Boston-based, ...